Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125203472 | 12520347 | 2 | F | 201510 | 20160708 | 20160701 | 20160713 | EXP | US-AMGEN-USASP2016082799 | AMGEN | 78.00 | YR | E | M | Y | 79.37000 | KG | 20160713 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125203472 | 12520347 | 1 | PS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | 40000 UNITS, AS NEEDED BELOW 10 | U | 103234 | SOLUTION FOR INJECTION | ||||||||
| 125203472 | 12520347 | 2 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | 10000 UNITS, EVERY OTHER DAY FOR 3 OR 4 DAYS | U | 103234 | SOLUTION FOR INJECTION | QD | |||||||
| 125203472 | 12520347 | 3 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | 20000 UNIT, UNK | U | 103234 | SOLUTION FOR INJECTION | ||||||||
| 125203472 | 12520347 | 4 | SS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | 40000 UNIT, UNK | U | 103234 | SOLUTION FOR INJECTION | ||||||||
| 125203472 | 12520347 | 5 | SS | BUMEX | BUMETANIDE | 1 | Unknown | 2 MG, TWICE A DAY | 0 | 2 | MG | BID | |||||||
| 125203472 | 12520347 | 6 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | UNK | 0 | ||||||||||
| 125203472 | 12520347 | 7 | C | COREG | CARVEDILOL | 1 | 25 MG, IN THE MORNING | 0 | 25 | MG | QD | ||||||||
| 125203472 | 12520347 | 8 | C | COREG | CARVEDILOL | 1 | 12.5 MG, AT NIGHT | 0 | 12.5 | MG | /hr | ||||||||
| 125203472 | 12520347 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | |||||||||
| 125203472 | 12520347 | 10 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 125203472 | 12520347 | 11 | C | IMDUR | ISOSORBIDE MONONITRATE | 1 | UNK | 0 | |||||||||||
| 125203472 | 12520347 | 12 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 125203472 | 12520347 | 13 | C | SINEMET | CARBIDOPALEVODOPA | 1 | 25/100 MG, 4 TIMES A DAY | 0 | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125203472 | 12520347 | 1 | Chronic kidney disease |
| 125203472 | 12520347 | 2 | Anaemia macrocytic |
| 125203472 | 12520347 | 5 | Chronic kidney disease |
| 125203472 | 12520347 | 6 | Product used for unknown indication |
| 125203472 | 12520347 | 7 | Cardiac failure congestive |
| 125203472 | 12520347 | 9 | Cardiac failure congestive |
| 125203472 | 12520347 | 10 | Blood cholesterol |
| 125203472 | 12520347 | 11 | Blood pressure abnormal |
| 125203472 | 12520347 | 12 | Thyroid disorder |
| 125203472 | 12520347 | 13 | Parkinson's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125203472 | 12520347 | HO |
| 125203472 | 12520347 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125203472 | 12520347 | Abnormal behaviour | |
| 125203472 | 12520347 | Adverse event | |
| 125203472 | 12520347 | Aphasia | |
| 125203472 | 12520347 | Blood potassium increased | |
| 125203472 | 12520347 | Blood urea abnormal | |
| 125203472 | 12520347 | Dyspnoea | |
| 125203472 | 12520347 | Erythema | |
| 125203472 | 12520347 | Feeling abnormal | |
| 125203472 | 12520347 | Fluid retention | |
| 125203472 | 12520347 | Gait disturbance | |
| 125203472 | 12520347 | Haemoglobin abnormal | |
| 125203472 | 12520347 | Haemoglobin decreased | |
| 125203472 | 12520347 | Implantable defibrillator insertion | |
| 125203472 | 12520347 | International normalised ratio increased | |
| 125203472 | 12520347 | Oedema | |
| 125203472 | 12520347 | Peripheral swelling | |
| 125203472 | 12520347 | Post procedural haematoma | |
| 125203472 | 12520347 | Transferrin saturation decreased | |
| 125203472 | 12520347 | Weight increased | |
| 125203472 | 12520347 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125203472 | 12520347 | 1 | 201503 | 0 | ||
| 125203472 | 12520347 | 2 | 201606 | 201606 | 0 | |
| 125203472 | 12520347 | 3 | 20160628 | 20160628 | 0 | |
| 125203472 | 12520347 | 4 | 20160629 | 0 | ||
| 125203472 | 12520347 | 6 | 201510 | 0 | ||
| 125203472 | 12520347 | 9 | 201606 | 0 |